Schrodinger, Inc. (SDGR, Financial) experienced a significant stock movement, with its share price soaring by 5.08%. The current stock price stands at $18.83, accompanied by a volume of 321,580 shares and a turnover rate of 0.44%. The stock's amplitude is recorded at 5.54%.
The latest financial report reveals that Schrodinger achieved a revenue of $47.33 million but reported a net loss of $54.05 million, translating to an earnings per share of -$0.74. The gross profit was $31.34 million, and the price-to-earnings ratio is at -6.74.
According to institutional ratings, out of 11 participating firms, 73% have given a buy recommendation, while 27% suggest holding the stock, with no firm recommending selling. Schrodinger operates within the health information services sector, which has seen an overall decline of 0.76%.
Other stocks in the sector showing notable activity include Mobile-Health Network Solutions, Euda Health Holdings Limited C/Wts 22/11/2027 (To Pur Com), and Healthcare Triangle, Inc., with the latter exhibiting high turnover rates and volatility.
About Schrodinger, Inc.: Schrodinger is a healthcare software company focusing on software sales and drug discovery. It generates revenue through software solutions, research funding, and milestone payments from drug discovery collaborations.
